Trials / Terminated
TerminatedNCT03506659
Electrochemical Skin Conductance in Evaluation of Chronic Neuropathy électrochimique cutanée
Electrochemical Skin Conductance in Evaluation of Chronic Neuropathy
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 4,000 (actual)
- Sponsor
- Erasme University Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
Use of cutaneous electrochemical conductance for preclinical screening of small-caliber nerve fibers
Detailed description
Objective: Use of cutaneous electrochemical conductance for preclinical screening of small-caliber nerve fibers Background: Sudoscan is a tool developed to evaluate and screen peripheral neuropathies in diabetes. His indication has been extended to other neuropathies such as post-chemotherapy, Fabry's disease, Parkinson's disease, familial amyloid polyneuropathy. Main objective: Evaluation of the relevance of cutaneous electrochemical conductance in chronic peripheral neuropathies. Methodology : Recruitment of 2 groups of 2000 patients Group 1: Patients with chronic neuropathy, during clinic bread consultation Group 2: Patients to benefit from scheduled surgery seen during anesthesia consultation For both groups filling the central awareness inventory questionnaire Analysis of the results after the recruitment has been completed.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | SUDO-SCAN Device | Sudo-scan is a machine with 2 palets for hands and 2 palets for foots. The patient has to put his 2 hands and 2 foots on the machine. The machine do the measures during 2 minutes. |
Timeline
- Start date
- 2018-03-01
- Primary completion
- 2020-01-30
- Completion
- 2020-01-30
- First posted
- 2018-04-24
- Last updated
- 2020-02-28
Locations
1 site across 1 country: Belgium
Source: ClinicalTrials.gov record NCT03506659. Inclusion in this directory is not an endorsement.